Novartis to acquire Tourmaline Bio in deal valuing it at $1.4 billion

Novartis to acquire Tourmaline Bio in deal valuing it at $1.4 billionSource: Reuters
أخبار الاستثمار والأسواق المالية من موقع Investing.com

Novartis to acquire Tourmaline Bio in deal valuing it at $1.4 billionSource: Reuters

Amnesty says Pakistan spying on millions through phone-tapping, firewallSource: Reuters

Ant digital unit puts $8 bln energy assets on its blockchain- BloombergSource: Investing.com

Vibe coding firm Supabase in talks to double valuation to $5 bln - The InformationSource: Investing.com

Asia stocks mixed amid Fed cut bets; Japan hits record high after PM resignationSource: Investing.com

US tariffs worsen challenges in the petrochemical industry, executives warnSource: Reuters

Japan’s Nikkei hits record high after PM Ishiba resignation, strong Q2 GDPSource: Investing.com

South Korea to send chartered plane to Atlanta to bring back workers detained in USSource: Reuters
Apple iPhone 17 launch: watch for price hikes, AI plans, Wedbush saysSource: Investing.com
Microsoft’s recent weakness presents buying opportunity: EvercoreSource: Investing.com